Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P528: Long-term outcome of ulcerative colitis patients responders to cyclosporine in the biological eraECCO '17 Barcelona
Year: 2017
Authors:

Bastida G.*1,2, Sargalt L.3, Garcia V.4, Mesonero F.5, Braithwaite A.M.6, Montserrat A.7, Martín M.D.8, Sicilia B.9, Olivares D.10, Vicente R.11, Rodriguez E.12, Navarro P.13, Lobaton T.3

1La Fe University Hospital, Gastroenterology, Valencia, Spain 2CIBEREHD, barcelona, Spain 3Hospital Universitari Germans Trias i Pujol, Gastroenterology, Badalona (Barcelona), Spain 4Hospital Universitario Reina Sofía, Clinical Digestive Unit, Cόrdoba, Spain 5Hospital Ramon y Cajalbania, Gastroenterology & Hepatology, Madrid, Spain 6Hospital Universitario La Fe, Department of Gastroenterology, Valencia, Spain 7Corporaciό Sanitària Parc Taulí, Gastrotenterology, Sabadell, Spain 8Hospital Universitario La Paz, Department of Gastroenterology, Madrid, Spain 9Universitary Hospital of Burgos, Burgos, Spain 10Hospital Clínico San Carlos, Department of Gastroenterology, Madrid, Spain 11University Hospital Miguel Servet, Aparato Digestivo, Zaragoza, Spain 12Hospital La Candelaria, Digestive Service, Santa Cruz De Tenerife, Spain 13Hospital Clinico Universitario, Valencia, Spain

P529: Impact of stress in inflammatory bowel disease. Effect of a group psychological intervention programECCO '17 Barcelona
Year: 2017
Authors:

Bernabeu P.1, Buades N.1, Alonso M.1, Van-der Hofstadt C.1, Gutiérrez A.*2,3, Sempere L.2, Rodríguez-Marín J.1, Jover R.2

1Hospital General Universitario Alicante, Psychology Department, Alicante, Spain 2Hospital General Universitario Alicante, Department of Gastroenterology, Alicante, Spain 3CIBEREHD, Madrid, Spain

P530: Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-upECCO '17 Barcelona
Year: 2017
Authors:

Cassieri C.*1, Pica R.1, Avallone E.V.1, Brandimarte G.2, Zippi M.1, Crispino P.1, De Nitto D.1, Lecca G.2, Corrado C.1, Vernia P.1, Paoluzi P.1, Corazziari E.S.1

1“Sapienza” University, Department of Internal Medicine and Medical Specialties, Rome, Italy 2“Cristo Re” Hospital, Department of Internal Medicine, Rome, Italy

P531: Discontinuation of corticosteroids among Crohn's disease patients treated with vedolizumab in the United StatesECCO '17 Barcelona
Year: 2017
Authors:

Patel H.*1, Chastek B.2, Null K.D.3, Demuth D.4

1Immensity Consulting, Inc., Chicago, United States 2Optum, Eden Prairie, United States 3Takeda Pharmaceuticals U.S.A., Inc., Health Economics and Outcomes Research, Deerfield, United States 4Takeda Development Center Europe Ltd, Evidence and Value Generation, London, United Kingdom

P532: Biosimilar infliximab in anti-TNF naive inflammatory bowel disease patients – one-year clinical follow-upECCO '17 Barcelona
Year: 2017
Authors:

Kolar M.*1, Duricova D.1,2, Bortlik M.1,3, Hruba V.1, Machkova N.1, Mitrova K.1,4, Lukas M.1, Malickova K.5, Lukas M.1,5

1ISCARE I.V.F. a.s., IBD Clinical and Research Centre, Prague, Czech Republic 21st Medical Faculty, Charles University, Institute of Pharmacology, Prague, Czech Republic 3Military Hospital, Charles University, Department of Internal Medicine, Prague, Czech Republic 42nd Medical Faculty and Motol Hospital, Department of Paediatrics, Prague, Czech Republic 51st Medical Faculty and General Teaching Hospital, Charles University, Institute of Medical Biochemistry, Prague, Czech Republic

P533: Anaemia and iron deficiency in gastroenterology: a Scandinavian prospective, observational study of iron isomaltoside in clinical practiceECCO '17 Barcelona
Year: 2017
Authors:

Frigstad S.O.*1,2,3, Hammarlund P.4, Bonderup O.5, Rannem T.6, Haaber A.7, Fallingborg J.8, Blom H.9, Bajor A.10,11, Hellström P.M.12

1Vestre Viken Hospital Trust, Department of Medicine Baerum Hospital, Drammen, Norway 2Østfold Hospital Trust, Department of Research, Grålum, Norway 3University of Oslo, Institute of Clinical Medicine, Oslo, Norway 4Angelholms Hospital, Department of Medicine, Angelholm, Sweden 5Silkeborg Regional Hospital, Department of Gastroenterology, Silkeborg, Denmark 6Nordsjaelland Hospital, Department of gastroenterology, Hilleroed, Denmark 7Herlev-Gentofte Hospital, Department of Gastroenterology, Hellerup, Denmark 8Aalborg University Hospital, Department of Medical Gastroenterology, Aalborg, Denmark 9Sunderby Hospital, Department of Medicine, Luleå, Sweden 10Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg, Sweden 11SÄS, Department of Medicine, Borås, Sweden 12Uppsala University Hospital, Department of Medical Sciences, Uppsala, Sweden

P534: Illness perception in IBD patients: a prospective studyECCO '17 Barcelona
Year: 2017
Authors:

Vegni E.1, Gilardi D.2, Corrò B.E.3, Menichetti J.4, Bonovas S.5, Leone D.1, Allocca M.2, Furfaro F.2, Danese S.2,6, Fiorino G.*7

1University of Milan, Department of Health Sciences, Milan, Italy 2Humanitas Research Hospital, IBD Center, Gastroenterology, Rozzano, Milan, Italy 3University of Milan, Milan, Italy 4Catholic University, Department of Psychology, Milan, Italy 5Humanitas Research Hospital, Department of Gastroenterology, IBD Center, Rozzano, Italy 6Humanitas University, Biomedical Sciences, Rozzano, Milan, Italy 7Humanitas Clinical and Research Center, IBD Center, Department of Gastroenterology, Rozzano, Italy

P535: Outcomes of endoscopic resections of large non-polypoid lesions inflammatory bowel disease: a single United Kingdom centre experienceECCO '17 Barcelona
Year: 2017
Authors:

Gulati S., Emmanuel A., Burt M., Hayee B., Haji A.

King's College Hospital, King's Institute of Therapeutic Endoscopy, London, United Kingdom

P536: Combination therapy of bone marrow mesenchymal stromal cells and azathioprine not affect the clinical course luminal Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Knyazev O.*1, Parfenov A.1, Fadeeva N.1,2, Konoplyannikov A.3, Kagramanova A.1, Ruchkina I.1

1Moscow Clinical Research Center, Department of Inflammatory Bowel Disease, Moscow, Russian Federation 2Moscow Clinical Research Center, Department of Inflammatory bowel disease, Moscow, Russian Federation 3Medical Radiological Scientific Center, Department of Stem Cells Therapy, Obninsk, Russian Federation

P537: Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?ECCO '17 Barcelona
Year: 2017
Authors:

Subramaniam K.*1,2, Watthayalage R.1, Neeman T.3, Pavli P.1,2

1Canberra Hospital, Gastroenterology and Hepatology Unit, Canberra, Australia 2Australian National University, ANU Medical School, Canberra, Australia 3Australian National University, Statistical Consulting Unit, Canberra, Australia

P538: Can enteral polymeric diet change the post-surgical outcome in Crohn's disease patients? A pilot studyECCO '17 Barcelona
Year: 2017
Authors:

Ceccarelli L.*1, Franceschi M.2, Bertani L.3, Nieri C.2, de Bortoli N.3, Mumolo G.1, Laino G.3, Albano E.3, Tapete G.3, Marchi S.3, Buccianti P.2, Costa F.1

1Pisa University Hospital, Department of Translational Research and new Technologies in medicine and surgery, Pisa, Italy 2Pisa University Hospital, Department of Surgery, Pisa, Italy 3University of Pisa, Department of Translational Research and new Technologies in medicine and surgery, Pisa, Italy

P539: Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013ECCO '17 Barcelona
Year: 2017
Authors:

Viola A.*1, Ferracane C.2, Costantino G.1, Alibrandi A.3, Inserra G.2, Fries W.1

1University of Messina, Dept. of Clinical and Experimental Medicine, Messina, Italy 2University of Catania, Dip. di Scienze Mediche e Pediatriche, UO Medicina Interna, Catania, Italy 3University of Messina, Department of Economical, Financial, Social, Environmental, Statistical and Territorial Sciences, Messina, Italy

P540: Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre studyECCO '17 Barcelona
Year: 2017
Authors:

Yamamoto T.*1, Tanaka T.2, Yokoyama T.3, Shimoyama T.1, Ikeuchi H.4, Uchino M.4, Watanabe T.2

1Yokkaichi Hazu Medical Centre, Inflammatory Bowel Disease Centre, Yokkaichi, Japan 2The University of Tokyo, Department of Surgical Oncology, Tokyo, Japan 3Yokoyama Hospital for Gastroenterological Diseases, Department of Surgery, Nagoya, Japan 4Hyogo College of Medicine, Department of Inflammatory Bowel Disease Surgery, Nishinomiya, Japan

P541: Intestinal failure: a rare but significant outcome of restorative proctocolectomyECCO '17 Barcelona
Year: 2017
Authors:

Segal J., Oke S., Clark S., Hart A.

St Mark's Hospital, Department of Gastroenterology, Harrow, United Kingdom

P542: Long-term outcomes after switching from originator infliximab to biosimilar in paediatric-onset inflammatory bowel disease patients: a single centre prospective observational studyECCO '17 Barcelona
Year: 2017
Authors:

Kang B., Lee K., Choe Y.H.

Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Pediatrics, Seoul, South Korea

P543: Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: the UK TRANSIT studyECCO '17 Barcelona
Year: 2017
Authors:

McCartney S.*1, Lindsay J.2, Russell R.3, Gaya D.3, Shaw I.4, Murray C.5, Finney-Hayward T.6, Sebastian S.7

1University College London Hospitals NHS Foundation Trust, London, United Kingdom 2Barts Health NHS Trust, London, United Kingdom 3NHS Greater Glasgow and Clyde, Glasgow, United Kingdom 4Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom 5Royal Free London NHS Foundation Trust, London, United Kingdom 6AbbVie, Maidenhead, United Kingdom 7Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

P544: Combination therapy of vedolizumab and a TNF antagonist in IBD patients with severe chronic active, therapy refractory disease courseECCO '17 Barcelona
Year: 2017
Authors:

Kuehbacher T.*1, Abu Hashem R.1, Langel N.1, Schreiber S.2, Drvarov O.1

1Asklepios Westklinikum Hamburg, Gastroenterology, Hamburg, Germany 2Christian Albrechts University Kiel, Department of Internal Medicine I, Kiel, Germany

P545: Clinical outcomes following a switch from Remicade® to the biosimilar CT-P13 in inflammatory bowel disease patients in clinical remission: preliminary resultsECCO '17 Barcelona
Year: 2017
Authors:

Guerrero Puente L.N.*1, Iglesias Flores E.1, Benítez Cantero J.M.1, Cárdenas Aranzana M.J.2, Medina Medina R.1, Salgueiro Rodríguez I.1, Aguilar Melero P.1, Manzanares Martin B.3, García-Sánchez V.1

1Hospital Universitario Reina Sofía, Clinical Unit Of Gastroenterology, Cόrdoba, Spain 2Hospital Universitario Reina Sofía, Clinical Unit Of Pharmacy, Cόrdoba, Spain 3Hospital Universitario Reina Sofía, Service Of Immunology, Cόrdoba, Spain

P546: Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease?ECCO '17 Barcelona
Year: 2017
Authors:

Serra K.*1, Rodríguez-Alonso L.1, Padullés N.2, Rodríguez-Moranta F.1, Arajol C.1, Gilabert P.1, Rodríguez R.1, Bas J.3, Morandeira-Rego F.3, Santacana E.2, Padullés A.2, Guardiola J.1

1Hospital Universitari de Bellvitge, Department of Gastroenterology, Barcelona, Spain 2Hospital Universitari de Bellvitge, Department of Pharmacy, Barcelona, Spain 3Hospital Universitari de Bellvitge, Department of Immunology, Barcelona, Spain

P547: Is there an association between bariatric surgery and Crohn's disease?ECCO '17 Barcelona
Year: 2017
Authors:

Brcic I.*1, Todoroff A.2, Baumgartner K.2, Langner C.1, Gröchenig H.P.3

1Medical University of Graz, Institute of Pathology, Graz, Austria 2Krankenhaus Barmherzige Brüder, Department of Surgery, St. Veit an der Glan, Austria 3Krankenhaus Barmherzige Brüder, Internal Medicine, St. Veit an der Glan, Austria